MBNL1 and diabetes mellitus: Our observations that Ro 31-8220 affects nuclear foci, MBNL1 distribution, ATP2A1 splicing and CELF1 steady-state protein levels independently of PKC activity suggests an additional target of this kinase inhibitor that may link these two aspects of DM pathophysiology.